Increased levels of hypoxia-sensitive proteins in allergic airway inflammation.
about
Arginase: a key enzyme in the pathophysiology of allergic asthma opening novel therapeutic perspectivesGlutathione redox control of asthma: from molecular mechanisms to therapeutic opportunitiesExpression of peroxiredoxin 1 and 4 promotes human lung cancer malignancyArginase and pulmonary diseasesOxidative stress and asthma: proteome analysis of chitinase-like proteins and FIZZ1 in lung tissue and bronchoalveolar lavage fluidSubstrate uptake and protein stability relationship in mammalian histidine decarboxylase.Real-time assessment of inflammation and treatment response in a mouse model of allergic airway inflammationStaphylococcus aureus elicits marked alterations in the airway proteome during early pneumonia.Proteomic and tissue array profiling identifies elevated hypoxia-regulated proteins in pancreatic ductal adenocarcinoma.A systems approach to mapping transcriptional networks controlling surfactant homeostasis.Enhanced interferon-gamma gene expression in T Cells and reduced ovalbumin-dependent lung eosinophilia in hypoxia-inducible factor-1-alpha-deficient miceIdentification of novel diagnostic biomarkers for asthma and chronic obstructive pulmonary disease.Regulatory cross-talk of mouse liver polyamine and methionine metabolic pathways: a systemic approach to its physiopathological consequences.Vasoactive Intestinal Peptide Knockout (VIP KO) mouse model of sulfite-sensitive asthma: up-regulation of novel lung carbonyl reductaseHypoxia inducible factor promotes murine allergic airway inflammation and is increased in asthma and rhinitis.Innate immune responses to lung-stage helminth infection induce alternatively activated alveolar macrophagesThe Three A's in Asthma - Airway Smooth Muscle, Airway Remodeling & Angiogenesis.Allergic rhinitis, asthma, airway biology, and chronic obstructive pulmonary disease in AJRCCM in 2004.Biomarkers of disease and treatment in murine and cynomolgus models of chronic asthma.Competitive metabolism of L-arginine: arginase as a therapeutic target in asthma.Allergic lung inflammation promotes atherosclerosis in apolipoprotein E-deficient mice.HIV-1-infected astrocytes and the microglial proteome.Cysteine cathepsin S as an immunomodulatory target: present and future trends.Arginase enzymes in isolated airways from normal and nitric oxide synthase 2-knockout mice exposed to ovalbumin.MyD88-dependent changes in the pulmonary transcriptome after infection with Chlamydia pneumoniae.Migrating leukocytes are the source of peroxiredoxin V during inflammation in the airwaysArginases I and II in lungs of ovalbumin-sensitized mice exposed to ovalbumin: sources and consequences.Eosinophilic crystalline pneumonia as a major cause of death in 129S4/SvJae mice.Variable overoxidation of peroxiredoxins in human lung cells in severe oxidative stress.Arginase inhibition protects against allergen-induced airway obstruction, hyperresponsiveness, and inflammation.Increased arginase activity in cystic fibrosis airways.Proteomic analysis of CD4+ T-lymphocytes in patients with asthma between typical therapy (controlled) and no typical therapy (uncontrolled) level.
P2860
Q24650052-70B58B92-9F1C-48CD-8DBC-1FCC575F2782Q27694579-F3E1194E-5090-4B9E-9CC2-095E57AB2E7CQ28248261-F4F19217-BA8B-4D93-AA4B-AC50CD3DE66BQ28385094-D689AF06-794D-495F-8429-2324A5CBE956Q28391874-F9E15FC5-95D0-4243-880F-8D9996929A2DQ30381183-65966FC0-8891-4684-AFD7-65EB14976A2FQ30484461-A2424CB6-5453-4598-AD39-0BD54CBA3B28Q30484594-DFB8C222-0D4B-4AF8-A3A7-5D0D9DE9F51BQ33458493-F090ACCB-C8EE-4270-937C-16E83D8159A4Q33640757-BD66DBC1-AAE2-4531-B1AE-5ECBDA1DB95DQ33669174-766752D9-FBCF-44DB-B21F-002345ED1B96Q33864443-E32ADAFE-0E56-44E3-8251-F14D0C0E49AAQ33983597-11B7DA49-3129-4A0B-B2D1-16DA4D2F8939Q34079440-0CD1A4D8-178A-4B43-A263-AF349268D069Q35022295-C9B5491B-B3A3-4911-B521-DD2443983E10Q35073787-924168FE-3818-4E68-8845-6F89E0C6388FQ35763560-2DF1590C-9B28-4CC1-8458-1E0B9693BA6DQ36080147-28AF3987-25CC-4820-A040-EB5D96BC9A9EQ36111679-1EB6F810-3A95-4549-B493-C40636ADD4A2Q36682074-B83B1E80-B5C9-4109-9F4E-F8FA3C766EB2Q36803560-643B529B-1CE3-487F-87E2-CF6A9890DFD3Q36965352-D8105DD2-6200-4AA0-AB5F-8BA265C2BE2BQ37082769-9E1EC6D2-3FA9-4B62-98B6-4C64EAD44487Q37151743-2BD4540B-2CE1-445F-9A1A-04CDF02A9217Q37860176-0318CD7A-1836-4CFE-873B-E5248F460B9BQ38582136-FEABC6CB-C1A2-44C4-8514-0D9A536C7FDBQ41969977-BC61914B-6A5A-42CD-86F5-5C5D21BCAD4CQ44169765-F985AC66-77AB-449D-B100-3E0623A26239Q45207494-CBEE05ED-336A-43F6-B4C7-6A5D01EFEDF0Q46516143-DFF8EDB3-D430-472A-9214-D924E2E98AB9Q46706389-38544B01-5265-4B50-9396-072A855656E3Q50443636-4AD53C84-CBE9-4C9E-B661-F48B9CEEE2E2
P2860
Increased levels of hypoxia-sensitive proteins in allergic airway inflammation.
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年学术文章
@wuu
2004年学术文章
@zh
2004年学术文章
@zh-cn
2004年学术文章
@zh-hans
2004年学术文章
@zh-my
2004年学术文章
@zh-sg
2004年學術文章
@yue
2004年學術文章
@zh-hant
name
Increased levels of hypoxia-sensitive proteins in allergic airway inflammation.
@en
Increased levels of hypoxia-sensitive proteins in allergic airway inflammation.
@nl
type
label
Increased levels of hypoxia-sensitive proteins in allergic airway inflammation.
@en
Increased levels of hypoxia-sensitive proteins in allergic airway inflammation.
@nl
prefLabel
Increased levels of hypoxia-sensitive proteins in allergic airway inflammation.
@en
Increased levels of hypoxia-sensitive proteins in allergic airway inflammation.
@nl
P2093
P2860
P1476
Increased levels of hypoxia-sensitive proteins in allergic airway inflammation.
@en
P2093
Anders Bucht
Gunnar Pejler
Ignacio Fajardo
Linda Svensson
P2860
P304
P356
10.1164/RCCM.200402-178OC
P407
P577
2004-05-19T00:00:00Z